VSIG4 and familial pancreatic carcinoma: In aggressive cancers (such as undifferentiated thyroid and pancreatic cancer), VSIG4-positive TAMS (VSIG4+ TAMs) regulate SPP1 through Kla modification, promoting neutrophil infiltration and impairing antigen-specific immunity, forming an immunosuppressive TME.